Study Reveals Complex Effects of Ketogenic Diet on Intestinal Cancer in Mice
The ketogenic diet, known for its high-fat and low-carbohydrate composition, has gained popularity for various health benefits, including weight loss and potential effects on conditions like epilepsy and Alzheimer's disease. However, its influence on cancer remains a topic of considerable debate. A recent study published in the journal Nature sheds light on this complex relationship, particularly focusing on its effects on intestinal cancer in mice genetically predisposed to developing tumors.
Researchers, led by Omer Yilmaz from MIT, conducted experiments to determine how the ketogenic diet impacts tumor growth in different parts of the intestine. They fed mice one of three diets: a ketogenic diet, a standard control diet, or a high-fat, high-calorie diet designed to induce obesity. Surprisingly, the results indicated that the ketogenic diet accelerated tumor growth in the small intestine while simultaneously suppressing tumor development in the colon.
This dual effect was unexpected and prompted the researchers to investigate further. They discovered that the outcomes were not driven by ketone bodies, which are often associated with the ketogenic diet, but rather by how intestinal cells metabolize dietary fat. Co-first author Fangtao Chi emphasized that increasing or eliminating ketone production did not alter tumor growth, highlighting that the effects were linked to fatty acid oxidation in intestinal cells.
The study found that mice on the ketogenic diet developed small intestinal tumors at rates comparable to those on the obesity-inducing diet, despite remaining lean. This raised questions about the mechanisms at play, particularly since previous research had suggested that ketone bodies like beta-hydroxybutyrate (BHB) might offer protective benefits against colorectal cancer. Instead, the researchers concluded that the high dietary fat content, rather than ketones, was the key factor influencing tumor growth.
As intestinal cells metabolize dietary fat for energy, they activate proteins known as PPARs, which promote the rapid division of intestinal stem cells. While this increased stem cell activity can aid in tissue repair, it also raises the risk of tumor formation, as Yilmaz explained. The findings challenge a 2022 study that posited ketone bodies as protective against colon cancer, reinforcing the need to differentiate between the effects of dietary fat and ketone supplements.
The implications of this research are significant, but the authors caution that the findings stem from a mouse model genetically predisposed to intestinal tumors, which may not fully translate to humans. They stress the necessity for further studies to explore whether similar mechanisms operate in human subjects. Additionally, the results suggest that commercially available ketone supplements may not replicate the observed risks or benefits, as the effects were primarily linked to fat metabolism rather than ketone levels.
The team is now focused on understanding why the ketogenic diet produces such divergent effects in neighboring parts of the intestine, a question that remains unanswered. The study's findings underscore the complexity of dietary impacts on health and the importance of continued research in this area.




